Neuroendocrine tumors of the lung

Cancers

Volumn 4, Issue 3, 2012, Pages 777-798

  Fisseler Eckhoff, Annette ^a   Demes, Melanie ^a  

^a DR HORST SCHMIDT KLINIKEN   (Germany)

Author keywords

Carcinoids; LCNEC; SCLC

Indexed keywords

BEVACIZUMAB; EVEROLIMUS; PEGINTERFERON ALPHA2B; SUNITINIB;

BRONCHUS CARCINOID; CANCER PROGNOSIS; CARCINOID; CELL HYPERPLASIA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIAGNOSTIC IMAGING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG BIOPSY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MOLECULAR PATHOLOGY; NEUROENDOCRINE TUMOR; POSITRON EMISSION TOMOGRAPHY; PRECANCER; REVIEW; THORAX RADIOGRAPHY; TUMOR LOCALIZATION;

EID: 84866922138     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers4030777     Document Type: Review

References (55)

1. Travis, W.D. Advances in neuroendocrine lung tumors. Ann. Oncol. 2010, 21, vii65-vii71.
2. Rekhtmann, N. Neuroendocrine tumors of the lung. Arch. Pathol. Lab. Med. 2010, 134, 1628-1638.
3. Bertino, E.M. Pulmonary neuroendocrine/carcinoid tumors. Cancer 2009, 115, 4434-4441.
4. Taal, B.G.; Visser, O. Epidemiology of neuroendocrine tumours. Neuroendocrin 2004, 80, 3-7.
5. Semin Chong, M.D. Teaching points for neuroendocrine tumors of the lung: Clinical, pathologic, and imaging findings. Radiographics 2006, 26, 41-58.
6. Moran, C.A. Neuroendocrine carcinomas of the lung. Am. Soc. Clin. Pathol. 2009, 131, 206-221.
7. Valente, M.; Catena, L.; Milione, M.; Pusceddu, S.; Formisano, B.; Bajetta, E. Common diagnostic challenges in the histopathologic diagnosis of neuroendocrine lung tumors: A case report. Case Rep. Oncol. 2010, 3, 202-207.
8. Travis, W.D., Brambilla, E., Muller-Hermelink, H.K., Harris, C.C., Eds. World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Lung, Pleura, Tymus and Heart; IARC Press: Lyon, France, 2004; pp.19-25.
9. Zander, D.S.; Popper, H.H.; Jagirdar, J.; Haque, A.K.; Cagle, P.T.; Barrios, R. Molecular Pathology Of Lung Diseases; Springer: New York, NY, USA, 2008.
10. Ginsberg, M.S.; Akin, O.; Berger, D.B.; Zakowski, M.F.; Panicek, D.M. Pulmonary tumolets: CT findings. Am. J. Roentgenol. 2004, 183, 293-296.
11. Churg, A.; Warnock, M.L. Pulmonary tumorlet. A form of peripheral carcinoid. Cancer 1976, 37, 1469-1477.
12. Warnock, M.L.; McCowin, M.D. Practical pathology of chest disease-Case studies. Available online: http://pathhsw5m54.ucsf.edu/introduction.html/(accessed on 28 April 2012).
13. Pelosi, G.; Zancanaro, C.; Sbabo, L.; Bresaola, E.; Martignoni, G.; Bontempini, L. Development of innumerable neuroendocrine tumorlets in pulmonary lobe scarred by intralobar sequestration. Immunohistochemical and ultrastructural study of an unusual case. Arch. Pathol. Lab. Med. 1992, 116, 1167-1174.
14. Johney, E.C.; Pfannschmidt, J.; Rieker, R.J.; Schnabel, P.A.; Mechtersheimer, G.; Dienemann, H. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and a typical carcinoid tumor. J. Thorac. Cardiovasc. Surg. 2006, 132, 1207-1208.
15. Cagle, P.T. Color Atlas and Text of Pulmonary Pathology; Lippincott William &Wilkins: Philadelphia, PA, USA, 2005.
16. Faggiano, A.; Ferella, P.; Grimaldi, F.; Campana, D.; Manzoni, M.; Davi, M.V.; Bianchi, A.; Valcavi, R.; Papini, E.; Giuffrida, D.; et al. Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian Epidemiological study: The NET management study. J. Endocrinol. Invest. 2011, PMID:22080849.
17. Gorshtein, A.; Gross, D.J.; Barak, D.; Strenov, Y.; Refaeli, Y.; Shimon, I.; Grozinsky-Glasberg, S. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors. Am. Cancer Soc. 2011, 118, 612-619.
18. Bakhshayesh Karam, M.; Zahirifard, S.; Tahbaz, M.O.; Kaynama, K.; Tolou, F.; Jabari Darjani, H. Bronchial carcinoid tumors: Clinical and radiological findings in 21 patients. J. Thorac. Cardiovasc. Surg. 2005, 2, 111-116
19. Sayeg, Y.; Bonnet, R. Neuroendocrine tumors of the lung. Available online: http://www.rhoenklinikum-ag.com/rka/cms/zbb_2/deu/download/Neuroendocrine_Tumors_of_the_Lung.pdf (accessed on 20 February 2012).
20. Grozinsky-Glasberg, S.; Shimon, I.; Korbonits, M.; Grossmann, A.B. Somatostatin analogues in the control of neuroendocrine tumours: Efficacy and mechanisms. Endocr. Relat. Cancer 2008, 15, 701-720.
21. Gatto, F.; Hofland, L.J. The role of somatostatin and dopamine D2 receptors in endocrine tumors. Endocr. Relat. Cancer 2011, 18, R233-R251.
22. Reghi, L.; Volante, M.; Tavaglione, V.; Bille, A.; Daniele, L.; Augusti, T.; Inzani, F.; Pelosi, G.; Rindi, G.; Papotti, M. Somatostatin receptor tissue distribution in lung neuroendocrine tumours: A clinicopathologic and immunohistochemical study if 218 clinically aggressive cases. Ann. Oncol. 2010, 21, 548-555
23. Terada, T. Pulmonary large cell neuroendocrine carcinoma diagnosed in brain metastasis. Int. J. Clin. Exp. Pathol. 2012, 5, 159-162.
24. Lowe, K.; Khithani, A.; Lui, E.; Winston, T.; Christian, D.; Saad, J.; Jeyarajah, D.R. Ki-67 labeling: A more sensitive indicator of malignant phenotype than mitotic count or tumor size? J. Surg. Oncol. 2012, doi:10.1002/jso.23124.
25. Erler, B.S.; Presby, M.M.; Finch, M.; Hodges, A.; Horowitz, K.; Topilow, A.A.; Matulewicz, T. CD117, Ki-67, and p53 predict survival in neuroendocrine carcinomas, but not within the subgroup of small cell lung carcinoma. Tumour Biol. 2011, 32, 107-111.
26. Skov, B.G.; Holm, B.; Erreboe, A.; Skov, T.; Mellemgaard, A. ERCC1 and Ki-67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: Distribution and impact on survival. J. Thorac. Oncol. 2010, 5, 453-459.
27. Asian, D.L.; Gulbahce, H.E.; Pambuccian, S.E.; Manivel, J.C.; Jessurun, J. Ki-67 immunoreactivity in the differential diagnosis of pulmonary neuroendocrine neoplasms in specimens with extensive crush artifact. Am. Clin. Pathol. 2005, 123, 874-878.
28. Waser, B.; Rehmann, R.; Sanchez, C.; Fourmy, D.; Reubi, J.C. Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors. J. Clin. Endocrinol. Metab. 2012, 97, 482-488.
29. Junker, K. Tumorregression bösartiger Lungentumoren; Habilitationsschrift., Medizinische Fakultät Bochum: Bochum, Germany, 1998; pp. 77-79, 92-94.
30. Junker, K.; Krapp, D.; Müller, K.-M. Kleinzelliges Bronchialkarzinom nach Chemotherapie-Morphologische Befunde. Pathologe 1995, 16, 217-222.
31. Edge, S.B., Byrd, D.R., Compton, C.C., Fritz, A.G., Greene, F.L., Trotti, A., Eds. American Joint Committee on Cancer Staging Manual, 7th ed.; Springer: New York, NY, USA; 2010.
32. Junker, K.; Thomas, M.; Schulmann, K.; Klinke, F.; Bosse, U.; Müller, K.-M. Tumor regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. J. Cancer Res. Clin. Oncol.1997, 123, 469-477.
33. Fisseler-Eckhoff, A.; Laberke, H.G.; Fischer, M.; Müller, K.-M. Karzinoidtumoren der Lunge und Asbest. Versicherungsmedizinische Aspekte. Pathologe 1998, 19, 425-429.
34. Nicholson, S.A.; Beasley, M.B.; Brambilla, E. Small cell lung carcinoma (SCLC): A clinicopathologic study of 100 cases with surgical specimens. Am. J. Surg. Pathol. 2002, 26, 1184-1197.
35. Müller, K.M.; Fisseler-Eckhoff, A. Small cell bronchial cancer-Pathologic anatomy. Langenbecks Arch. Chir. Suppl. Kongressbd. 1991, 1991, 534-543.
36. Elliott, J.A.; Osterlind, K.; Hirsch, F.R.; Hansen, H.H. Metastatic patterns in small-cell lung cancer: Correlation of autopsy findings with clinical parameters in 537 patients. J. Clin. Oncol. 1987, 5, 246-254.
37. Abeloff, M.D.; Eggleston, J.C.; Mendelsohn, G.; Ettinger, D.S.; Baylin, S.B. Changes in morphologic and biochemical characteristics of small cell carcinoma of the lung: A clinicopathologic study. Am. J. Med. 1979, 66, 757-764.
38. Waddell, T.K.; Shepherd, F.A. Should aggressive surgery ever be part of the management of small cell lung cancer? Thorac. Surg. Clin. 2004, 14, 271-281.
39. Skuladottin, H.; Hirsch, F.H.; Hansen, H.H.; Olsen, J.H. Pulmonary neuroendocrine tumors: Incidence and prognosis of histological subtypes. A population-based study in Denmark. Lung Cancer 2002, 37, 127-135.
40. Isaka, M.; Nakagawa, K.; Ohde, Y.; Okumura, T.; Watanabe, R.; Ito, I.; Nakajima, T.; Kondo, H. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: Differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma. Eur. J. Cardiothorac. Surg. 2012, 41, 841-846.
41. Johnson, R.; Trocha, S.; McLawhorn, M.; Worley, M.; Wheeler, G.; Thompson, L.; Schisler, N.; Schammel, D.; Schammel, C.; Stephenson, J.; Bolton, W. Histology, not lymph node involvement, predicts long-term survival in bronchopulmonary carcinods. Am. Surg. 2011, 77, 1669-1674.
42. Martini, N.; Zaman, M.B.; Bains, M.S.; Burt, M.E.; McCormack, P.M.; Rusch, V.W.; Ginsberg, R.J. Treatment and prognosis in bronchial carcinoids involving regional lymph nodes. J. Thorac. Cardiovasc. Surg. 1994, 107, 1-6.
43. Sun, J.M.; Ahn, M.J.; Um, S.W.; Kim, H.; Kim, H.K.; Choi, Y.S.; Han, J.; Kim, J.; Kwon, O.J.; Shim, Y.M.; Park, K. Chemotherapy for pulmonary large cell neuroendocrine carcinoma: Similar to that for small cell lung cancer of non-small cell lung cancer? Lung Cancer 2012, 77, 365-370.
44. Kenmotsu, Y.; Oshita, F.; Sugiura, M.; Murakami, S.; Kondo, T.; Saito, H.; Yamada, K. Anticancer Res. 2012, 32, 1453-1456.
45. Fournel, L.; Falcoz, P.E.; Alifano, M.; Charpentier, M.C.; Boudaya, M.S.; Magdeleinat, P.; Damotte, D.; Regnard, J.F. Surgical management of pulmonary large cell neuroendocrine carcinomas: A 10-year experience. Eur. J. Cardiothorac Surg. 2012, 42, 2.
46. Abedalla, N.; Tremblay, L.; Baey, C.; Fabre, D.; Planchard, D.; Pignon, J.P.; Guigay, J.; Pechoux, C.L.; Soria, J.C.; de Montpreville, V.T.; et al. Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma. J. Thorac. Oncol. 2012, 7, 1179-1183.
47. de Pas, T.M.; Giovannini, M.; Manzotti, M.; Trifiro, G.; Toffalorio, F.; Catania, C.; Spaggiari, L.; Labianca, R.; Barberis, M. Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gifitinib. J. Clin. Oncol. 2011, 29, 819-822.
48. Pelosi, G.; Rodrigues, J.; Viale, G.; Rosai, J. Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens. Am. J. Surg. Pathol. 2005, 29, 179-187.
49. Bertina, E.M.; Confer, P.D.; Colonna, J.E.; Ross, P.; Otterson, G.A. Pulmonary neuroendocrine/carcinoid tumors. Cancer 2009, 115, 4434-4441.
50. Johnson, B.E.; Russel, E.; Simmons, A.M.; Phelbs, R.; Steinberg, S.M.; Ihde, D.C.; Gazdar, A.F. Myc family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer. J. Cell Biochem. 1996, 24, 210-217.
51. Walch, A.K.; Zitzelberger, H.F.; Aubele, M.M.; Mattis, A.E.; Bauchinger, M.; Candidus, S.; Prauer, H.W.; Werner, M.; Hofler, H. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Am. J. Pathol. 1998, 153, 1089-1098.
52. Swarts, D.R.; Ramaekers, F.C.; Speel, E.J. Molecular and cellular biology of neuroendocrine lung tumors: Evidence for separate biological entities. Biochim. Biophys. Acta 2012, 1826, 255-271.
53. Sartelet, H.; Decaussin, M.; Devouassoux, G.; Nawrocki-Raby, B.; Brichon, P.-Y.; Brambilla, C.; Brambilla, E. Expression of vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1 [Flt-1] and VEGF-R2 [KDR/Flk-1]) in tumorlets and in neuroendocrine cell hyperplasia of the lung. Hum. Pathol. 2004, 35, 1210-1217.
54. Edmonston, T.B.; Kushnir, M.; Aharonov, R.; Lithwick Yanai, G.; Benjamin, H.; Bibbo, M.; Thurm, C.; Horowitz, L.; Huang, Y.; Gilad, S.; et al. MicroRNAs as clinical biomarkers for lung cancer classification (Meeting abstract). AACR 2010, No. 145.
55. Meiri, M.; Spector, Y.; Cohen, L.; Rosenwald, S.; Bentwich, Z.; Perelman, M.; Aharonov, R.; Barshack, I. MicroRNAs as powerful diagnostic tools for the differential diagnosis of lung tumors (Meeting abstract). J. Clin. Oncol. 2008, 26, No. 15_suppl 11112.